Bedoelde u
sans-cov-2

Zoekresultaten - 119 results

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol

Desombere, Isabelle; Van Damme, Pierre; Goossens, Herman; Buret, Laëtitia; Duysburgh, Els; Coenen, Samuel Source: BMJ Open, Volume 12, Issue 1 (2022) Health Topics:  SARS-CoV-2 Service:  Infections liées aux ...

Factors influencing SARS-CoV-2 infection rate in Belgian nursing homes’ residents during the first wave of COVID-19 pandemic

was organised testing all NH residents and staff. We analysed data of Flemish NH to identify institutional factors associated with increased SARS-CoV-2 infection rates among NH residents. ...

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

Van Den Bruel, Ann; Desombere, Isabelle; Van Damme, Pierre; Goossens, Herman; Buret, Laëtitia; Duysburgh, Els; Coenen, Samuel Source: BMJ Open, Volume 12, Issue 9 (2022) Health Topics:  SARS-CoV-2 ...

Risk assessment of SARS‐CoV‐2 infection in free‐ranging wild animals in Belgium

Publication Type: Peer reviewed scientific article Authors: Myriam Logeot; Mauroy, Axel; Thiry, Etienne; Nick De Regge; Vervaeke, Muriel; Olivier Beck; Valérie De Waele; Thierry van den Berg Source: Transboundary and Emerging Diseases (2021) Health Topics ...

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.

NHR, are known to have decreased antibody responses upon vaccination targeting other viral antigens. OBJECTIVES: As real-world data on vaccine responsiveness, we assessed the prevalence of SARS-CoV-2 ...

SARS-CoV-2 Surveillance in Belgian Wastewaters

alerting indicator Correlation public health authority SARS-CoV-2 Surveillance viral load per capita viral to faecal ratio wastewater-based epidemiology Abstract: Wastewater-based surveillance was conducted ...

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.

Humans SARS-CoV-2 Treatment Outcome Abstract: OBJECTIVES: This study aimed to assess the efficacy and safety of 300 mg camostat mesylate three times daily in a fasted state to treat early phase COVID-19 in ...

Hepatitis of unknown aetiology in children- epidemiological overview of cases reported in Europe, 1 January to 16 June 2022.

Ardiana; Duffell, Erika; Pebody, Richard Source: Euro Surveill, Volume 27, Issue 31 (2022) Keywords: Child COVID-19 Europe Hepatitis A Hospitalization Humans SARS-CoV-2 Abstract: Following the report of an ...

QR code

QR code for this page URL